SCHEMBL6375790

SCHEMBL6375790

C=CCc1ccccc1OCCOc1ccc(C=O)cc1OC

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.68
MAPT P10636 10/20 0.61
ALDH1A1 P00352 10/20 0.61
HPGD P15428 7/20 0.61
CYP2C9 P11712 3/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C19 P33261 2/20 0.61
CYP2D6 P10635 1/20 0.61
SMN1; SMN2 Q16637 4/20 0.57
HTT P42858 3/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
LMNA P02545 3/20 0.56
HSP90AA1 P07900 1/20 0.56
KDM4E B2RXH2 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
TSHR P16473 1/20 0.51
TTR P02766 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17833422 0.83 FDPS (0.68) FDPSMAPTALDH1A1HPGDCYP2C9
SCHEMBL5973815 0.82 FDPS (1.00) FDPSMAPTALDH1A1HPGDCYP2C9
SCHEMBL12325234 0.81 MEN1 (0.46) FDPSMAPTALDH1A1HPGDCYP2C9
SCHEMBL13856147 0.81 SIRT2 (0.56) MAPTALDH1A1HPGDCYP2C19CYP2D6
SCHEMBL21159060 0.81 ALDH1A1 (0.58) FDPSMAPTALDH1A1HPGDCYP2C9
SCHEMBL9442186 0.81 FDPS (0.90) FDPSMAPTALDH1A1HPGDCYP2C9
SCHEMBL9442183 0.79 FDPS (0.87) FDPSMAPTALDH1A1HPGDCYP2C9
SCHEMBL8719147 0.79 FDPS (0.87) FDPSMAPTALDH1A1HPGDCYP2C9
SCHEMBL12783892 0.79 HSD17B10 (0.70) MAPTALDH1A1HPGDCYP2C9CYP1A2
SCHEMBL16134409 0.79 FDPS (0.79) FDPSMAPTALDH1A1HPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005072731-A1 3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS X-CEPTOR THERAPEUTICS, INC. (US) 2005-08-11 WO disclosed
WO-2005072731-A1 3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS X-CEPTOR THERAPEUTICS, INC. (US) 2005-08-11 WO disclosed